Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 39,760 | 24,000 |
| Marketable Securities | N/A | N/A | N/A | 53,070 | 52,490 |
| Receivables | N/A | N/A | N/A | 1,670 | 2,980 |
| Inventories | N/A | N/A | N/A | 6,720 | 6,470 |
| Other current assets | 0 | 0 | 0 | 6,682 | 13,300 |
| TOTAL | $N/A | $N/A | $N/A | $112,320 | $99,240 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 17,630 | N/A |
| Intangibles | 0 | 0 | 0 | 46,880 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 13,220 | 49,940 |
| TOTAL | $N/A | $N/A | $N/A | $77,730 | $49,940 |
| Total Assets | $N/A | $N/A | $N/A | $174,200 | $164,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 42,330 | 27,810 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 8,020 | 7,000 |
| Accrued Expenses | N/A | N/A | N/A | 5,660 | 5,710 |
| Other current liabilities | N/A | N/A | N/A | 7,160 | 7,110 |
| TOTAL | $N/A | $N/A | $N/A | $70,840 | $47,720 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,270 | 68,020 |
| Deferred Revenues | N/A | N/A | N/A | 1,336 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 2,330 | 8,550 |
| TOTAL | $N/A | $N/A | $N/A | $3,600 | $76,600 |
| Total Liabilities | $N/A | $N/A | $N/A | $149,310 | $124,330 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 6,180 | 5,990 |
| Retained earnings | N/A | N/A | N/A | -320,450 | -293,300 |
| Other shareholders' equity | 0 | 0 | 0 | -7,420 | -2,320 |
| TOTAL | $N/A | $N/A | $N/A | $24,890 | $40,040 |
| Total Liabilities And Equity | $0 | $0 | $0 | $174,200 | $164,370 |